Diatos SA

Promethera Biosciences, a Belgian biotechnology company developing a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, has named Dr John Tchelingerian c

TOKYO – Astellas Pharma Inc. has created what it calls a "uniquely structured partnership" in out-licensing a compound to Drais Pharmaceuticals Inc. ,which in turn established a virtual company

TOKYO – Astellas Pharma Inc. has created what it calls a "uniquely structured partnership" in out-licensing a compound to Drais Pharmaceuticals Inc. ,which in turn established a virtual company

An increase in demand from small- and medium-sized drug development companies for non-clinical development support has led to one young CRO, Leads to Development (L2D), opening new two new offices alo